Montreal Gen Hosp / Div of Clin Immuno and Allergy
Montreal, Quebec, Canada
Medical institution in Montreal, Quebec
1001 Decarie Blvd, Montreal, Quebec H4A 3J1
1,379 Beds
About Montreal Gen Hosp / Div of Clin Immuno and Allergy
The McGill University Health Centre is one of two major healthcare networks in the city of Montreal, Quebec. It is affiliated with McGill University and is one of the largest medical institutions in Canada. It is the largest hospital system in Canada by bed capacity.
There are 1,379 beds in Montreal Gen Hosp / Div of Clin Immuno and Allergy.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
2
Allergy Therapeutics
1
Cytran
1
Dynavax Technologies Corporation
1
Hoffmann-La Roche
1
OXO Chemie
1
Clinical Trials at Montreal Gen Hosp / Div of Clin Immuno and Allergy
During the past decade, Montreal Gen Hosp / Div of Clin Immuno and Allergy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
Completed
140
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
Completed
240
The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
1996-06-01
1997-12-01
Completed
80
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
Completed
200
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
2001-02-01
2003-09-01
Completed
An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber
2007-09-01
2008-05-01
Completed
271
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Allergy Therapeutics" with 1 trials
sponsored, "Cytran" with 1 trials sponsored, "Dynavax Technologies Corporation" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Montreal Gen Hosp / Div of Clin Immuno and Allergy
According to Clinical.Site data, the most researched conditions in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" are
"HIV Infections" (5 trials), "Rhinitis, Allergic, Seasonal" (1 trials), "Sarcoma, Kaposi" (1 trials) and "Type I Hypersensitivity" (1 trials). Many other conditions were trialed in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" in a lesser frequency.
Clinical Trials Intervention Types at Montreal Gen Hosp / Div of Clin Immuno and Allergy
Most popular intervention types in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Lamivudine" (2 trials), "Stavudine" (2 trials), "Zidovudine" (2 trials), "Amb a 1 Immunostimulatory Oligoribonucleotide Conjugate" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Montreal Gen Hosp / Div of Clin Immuno and Allergy
The vast majority of trials in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" are
7 trials for "All" genders.
Clinical Trials Status at Montreal Gen Hosp / Div of Clin Immuno and Allergy
Currently, there are NaN active trials in "Montreal Gen Hosp / Div of Clin Immuno and Allergy".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Montreal Gen Hosp / Div of Clin Immuno and Allergy,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Montreal Gen Hosp / Div of Clin Immuno and Allergy, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".